tradingkey.logo
tradingkey.logo
Pesquisar

Twist Bioscience Corp

TWST
Adicionar à lista de desejos
99.240USD
-3.010-2.94%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
6.08BValor de mercado
PerdaP/L TTM

Mais detalhes de Twist Bioscience Corp Empresa

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Informações de Twist Bioscience Corp

Código da empresaTWST
Nome da EmpresaTwist Bioscience Corp
Data de listagemOct 31, 2018
CEOLeproust (Emily M)
Número de funcionários979
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 31
Endereço681 Gateway Blvd.
CidadeSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94080
Telefone18007190671
Sitehttps://www.twistbioscience.com/
Código da empresaTWST
Data de listagemOct 31, 2018
CEOLeproust (Emily M)

Executivos da empresa Twist Bioscience Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.12K
-84.57%
Ms. Trynka Shineman Blake
Ms. Trynka Shineman Blake
Director
Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

Perguntas frequentes

Quem são os cinco principais acionistas de Twist Bioscience Corp?

Os cinco principais acionistas de Twist Bioscience Corp são: Dr. Emily M. Leproust, Ph.D.

Quantas instituições possuem ações da Twist Bioscience Corp (TWST)?

Em 2026Q1, 592 instituições possuíam ações da Twist Bioscience Corp, com valor de mercado aproximado de 78.48M, representando 126.03% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -339291.00.

Qual é a maior fonte de receita da Twist Bioscience Corp?

Em 2026Q1, o segmento de negócios NGS applications gerou a maior receita para Twist Bioscience Corp, totalizando 52.64M e representando 50.76% da receita total.